Inari Medical, Inc.
NARI · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,636 | -$29,267 | $9,840 | $13,789 |
| Dep. & Amort. | $10,735 | $7,119 | $4,308 | $1,385 |
| Deferred Tax | -$584 | $0 | $47 | $4,202 |
| Stock-Based Comp. | $40,337 | $28,671 | $25,448 | $3,524 |
| Change in WC | $2,638 | -$21,468 | -$14,300 | -$21,169 |
| Other Non-Cash | -$15,563 | $973 | $143 | $181 |
| Operating Cash Flow | $35,927 | -$13,972 | $25,486 | $1,912 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,710 | -$9,951 | -$13,645 | -$5,460 |
| Net Acquisitions | -$240,419 | $185,265 | $37,377 | $0 |
| Inv. Purchases | -$406,738 | -$497,865 | -$134,377 | -$49,977 |
| Inv. Sales/Matur. | $595,340 | $312,600 | $97,000 | $0 |
| Other Inv. Act. | -$1,491 | -$185,265 | -$37,377 | -$49,977 |
| Investing Cash Flow | -$58,018 | -$195,216 | -$51,022 | -$55,437 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$20,250 |
| Stock Issued | $9,921 | $182,817 | $5,558 | $164,361 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$8,750 | -$5,679 | -$1,485 | $4 |
| Financing Cash Flow | $1,171 | $177,138 | $4,073 | $144,115 |
| Forex Effect | -$94 | -$480 | -$402 | $0 |
| Net Chg. in Cash | -$21,014 | -$32,530 | -$21,865 | $90,590 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $60,222 | $92,752 | $114,617 | $24,027 |
| End Cash | $39,208 | $60,222 | $92,752 | $114,617 |
| Free Cash Flow | $29,726 | -$23,923 | $11,841 | -$3,548 |